Recent trends in cancer survival across Europe between 2000 and 2004: A model-based period analysis from 12 cancer registries

被引:93
作者
Gondos, A. [1 ]
Bray, F. [2 ]
Brewster, D. H. [3 ]
Coebergh, J. W. W. [4 ,5 ]
Hakulinen, T. [6 ]
Janssen-Heijnen, M. L. G. [4 ]
Kurtinaitis, J. [7 ]
Brenner, H. [1 ]
机构
[1] German Canc Res Ctr, Div Clin Epidemiol & Ageing Res, D-69115 Heidelberg, Germany
[2] Inst Population Bbased Canc Res, Canc Registry Norway, N-0310 Oslo, Norway
[3] NHS Natl Serv Scotland, Informat Serv Div, Scottish Canc Registry, Edinburgh EH12 9EB, Midlothian, Scotland
[4] Comprehens Canc Ctr S IKZ, Eindhoven Canc Registry, NL-5600 AE Eindhoven, Netherlands
[5] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands
[6] Finnish Canc Registry, FI-00170 Helsinki, Finland
[7] Vilnius Univ, Inst Oncol, Canc Registry Lithuana, LT-2007 Lietuva, Lithuania
关键词
survival; neoplasm; Europe; model-based period analysis;
D O I
10.1016/j.ejca.2008.03.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Monitoring population-based cancer survival is an essential component in the evaluation of cancer control, but subject to an inherent delay in the reporting of the most recent survival estimates with traditional techniques of analysis. Methods: We examined survival trends between the years 2000 and 2004 for 20 common cancers based on follow-up data from 12 cancer registries from diverse areas of Europe using model-based period analysis techniques. Results: Between 2000 and 2004, marked rises were seen in 5-year relative survival amongst patients with prostate, breast and colorectal cancer, which were statistically significant in 10, 8 and 7 of the 12 participating cancer registries, respectively. For cancer sites amenable to effective early detection and treatment, major geographical differences in patient prognosis still persisted, with a lower survival generally observed in Eastern European countries. Conclusion: Model-based period analysis enables the timely monitoring of recent trends in population -based cancer survival. For colorectal and breast cancers, the identified rises in survival are probably (at least partly) explained by the improvements in clinical care and the management of the disease. Nevertheless, persisting geographic differences do point to the potential for a further reduction in the burden of cancer throughout Europe, towards which improvements in diverse areas of care, including secondary prevention, access to advances in treatment as well as subspecialisation and regionalisation of oncologic care may all contribute. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1463 / 1475
页数:13
相关论文
共 66 条
[61]  
*WHO, CANC MOND STAT INF S
[62]   A national strategic change in treatment policy for rectal cancer implementation of total mesorectal excision as routine treatment in Norway. A national audit [J].
Wibe, A ;
Moller, B ;
Norstein, J ;
Carlsen, E ;
Wiig, JN ;
Heald, RJ ;
Langmark, F ;
Myrvold, HE ;
Soreide, O .
DISEASES OF THE COLON & RECTUM, 2002, 45 (07) :857-866
[63]  
WILT TJ, 2008, ANN INTERN MED
[64]   Adjuvant treatment of colorectal cancer [J].
Wolpin, Brian M. ;
Meyerhardt, Jeffrey A. ;
Mamon, Harvey J. ;
Mayer, Robert J. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (03) :168-185
[65]   Are differences in stage at presentation a credible explanation for reported differences in the survival of patients with colorectal cancer in Europe? [J].
Woodman, CBJ ;
Gibbs, A ;
Scott, N ;
Haboubi, NY ;
Collins, S .
BRITISH JOURNAL OF CANCER, 2001, 85 (06) :787-790
[66]   Closing the gap: Cancer in Central and Eastern Europe (CEE) [J].
Zatonski, Witold ;
Didkowska, Joanna .
EUROPEAN JOURNAL OF CANCER, 2008, 44 (10) :1425-1437